Literature DB >> 19279319

Variation in GIGYF2 is not associated with Parkinson disease.

W C Nichols1, D K Kissell, N Pankratz, M W Pauciulo, V E Elsaesser, K A Clark, C A Halter, A Rudolph, J Wojcieszek, R F Pfeiffer, T Foroud.   

Abstract

OBJECTIVE: A recent study reported that mutations in a gene on chromosome 2q36-37, GIGYF2, result in Parkinson disease (PD). We have previously reported linkage to this chromosomal region in a sample of multiplex PD families, with the strongest evidence of linkage obtained using the subset of the sample having the strongest family history of disease and meeting the strictest diagnostic criteria. We have tested whether mutations in GIGYF2 may account for the previously observed linkage finding.
METHODS: We sequenced the GIGYF2 coding region in 96 unrelated patients with PD used in our original study that contributed to the chromosome 2q36-37 linkage signal. Subsequently, we genotyped the entire sample of 566 multiplex PD kindreds as well as 1,447 controls to test whether variants in GIGYF2 are causative or increase susceptibility for PD.
RESULTS: We detected three novel variants as well as one of the previously reported seven variants in a total of five multiple PD families; however, there was no consistent evidence that these variants segregated with PD in these families. We also did not find a significant increase in risk for PD among those inheriting variants in GIGYF2 (p = 0.28).
CONCLUSIONS: We believe that variation in a gene other than GIGYF2 accounts for the previously reported linkage finding on chromosome 2q36-37.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19279319      PMCID: PMC2690967          DOI: 10.1212/01.wnl.0000346517.98982.1b

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  21 in total

1.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician.

Authors:  M F Folstein; S E Folstein; P R McHugh
Journal:  J Psychiatr Res       Date:  1975-11       Impact factor: 4.791

2.  Insulin receptor mRNA in the substantia nigra in Parkinson's disease.

Authors:  M Takahashi; T Yamada; I Tooyama; I Moroo; H Kimura; T Yamamoto; H Okada
Journal:  Neurosci Lett       Date:  1996-02-09       Impact factor: 3.046

3.  Type 2 diabetes and the risk of Parkinson's disease.

Authors:  Gang Hu; Pekka Jousilahti; Siamak Bidel; Riitta Antikainen; Jaakko Tuomilehto
Journal:  Diabetes Care       Date:  2007-01-24       Impact factor: 19.112

4.  The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects.

Authors:  G Blessed; B E Tomlinson; M Roth
Journal:  Br J Psychiatry       Date:  1968-07       Impact factor: 9.319

Review 5.  The insulin-like growth factor system and its pleiotropic functions in brain.

Authors:  V C Russo; P D Gluckman; E L Feldman; G A Werther
Journal:  Endocr Rev       Date:  2005-08-30       Impact factor: 19.871

6.  Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.

Authors:  A J Hughes; S E Daniel; L Kilford; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-03       Impact factor: 10.154

7.  Two novel proteins that are linked to insulin-like growth factor (IGF-I) receptors by the Grb10 adapter and modulate IGF-I signaling.

Authors:  Barbara Giovannone; Eunhee Lee; Luigi Laviola; Francesco Giorgino; Kelly A Cleveland; Robert J Smith
Journal:  J Biol Chem       Date:  2003-05-27       Impact factor: 5.157

8.  LRRK2 mutation analysis in Parkinson disease families with evidence of linkage to PARK8.

Authors:  W C Nichols; V E Elsaesser; N Pankratz; M W Pauciulo; D K Marek; C A Halter; A Rudolph; C W Shults; T Foroud
Journal:  Neurology       Date:  2007-09-05       Impact factor: 9.910

9.  Genome-wide linkage analysis and evidence of gene-by-gene interactions in a sample of 362 multiplex Parkinson disease families.

Authors:  Nathan Pankratz; William C Nichols; Sean K Uniacke; Cheryl Halter; Jill Murrell; Alice Rudolph; Clifford W Shults; P Michael Conneally; Tatiana Foroud
Journal:  Hum Mol Genet       Date:  2003-08-12       Impact factor: 6.150

View more
  9 in total

1.  The contribution of GIGYF2 to Parkinson's disease: a meta-analysis.

Authors:  Yuan Zhang; Qi-Ying Sun; Ren-He Yu; Ji-Feng Guo; Bei-Sha Tang; Xin-Xiang Yan
Journal:  Neurol Sci       Date:  2015-07-08       Impact factor: 3.307

2.  Common variants in PARK loci and related genes and Parkinson's disease.

Authors:  Sun Ju Chung; Sebastian M Armasu; Joanna M Biernacka; Timothy G Lesnick; David N Rider; Sarah J Lincoln; Alexandra I Ortolaza; Matthew J Farrer; Julie M Cunningham; Walter A Rocca; Demetrius M Maraganore
Journal:  Mov Disord       Date:  2010-12-13       Impact factor: 10.338

Review 3.  Genetics of Parkinson disease and essential tremor.

Authors:  Christian Wider; Owen A Ross; Zbigniew K Wszolek
Journal:  Curr Opin Neurol       Date:  2010-08       Impact factor: 5.710

4.  Meta-analyses of seven GIGYF2 polymorphisms with Parkinson's disease.

Authors:  Dongjun Dai; Yunliang Wang; Xingyu Zhou; Jianmin Tao; Danjie Jiang; Hanlin Zhou; Yi Jiang; Guanghui Pan; Ping Ru; Huihui Ji; Jinfeng Li; Yuzheng Zhang; Honglei Yin; Mingqing Xu; Shiwei Duan
Journal:  Biomed Rep       Date:  2014-07-31

5.  Non-synonymous GIGYF2 variants in Parkinson's disease from two Asian populations.

Authors:  Eng-King Tan; Chin-Hslen Lin; Chun-Hwei Tai; Louis C Tan; Meng-Ling Chen; R Li; Hui-Qin Lim; Ratnagopal Pavanni; Yih Yuen; K M Prakash; Yi Zhao; Ruey-Meei Wu
Journal:  Hum Genet       Date:  2009-05-16       Impact factor: 4.132

6.  GIGYF2 gene disruption in mice results in neurodegeneration and altered insulin-like growth factor signaling.

Authors:  Barbara Giovannone; William G Tsiaras; Suzanne de la Monte; Jan Klysik; Corinne Lautier; Galina Karashchuk; Stefano Goldwurm; Robert J Smith
Journal:  Hum Mol Genet       Date:  2009-09-10       Impact factor: 6.150

7.  Association study of DNAJC13, UCHL1, HTRA2, GIGYF2, and EIF4G1 with Parkinson's disease.

Authors:  Prabhjyot Saini; Uladzislau Rudakou; Eric Yu; Jennifer A Ruskey; Farnaz Asayesh; Sandra B Laurent; Dan Spiegelman; Stanley Fahn; Cheryl Waters; Oury Monchi; Yves Dauvilliers; Nicolas Dupré; Lior Greenbaum; Sharon Hassin-Baer; Alberto J Espay; Guy A Rouleau; Roy N Alcalay; Edward A Fon; Ronald B Postuma; Ziv Gan-Or
Journal:  Neurobiol Aging       Date:  2020-10-31       Impact factor: 4.673

8.  Genetic analysis of indel markers in three loci associated with Parkinson's disease.

Authors:  Zhixin Huo; Xiaoguang Luo; Xiaoni Zhan; Qiaohong Chu; Qin Xu; Jun Yao; Hao Pang
Journal:  PLoS One       Date:  2017-09-05       Impact factor: 3.240

9.  Genetic basis of Parkinson's disease: inheritance, penetrance, and expression.

Authors:  Claudia Schulte; Thomas Gasser
Journal:  Appl Clin Genet       Date:  2011-06-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.